2 assets in Aspartylglucosaminuria

Therapeutic assets addressing Aspartylglucosaminuria, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Busulfanum Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cald Hr-D Aspartylglucosaminuria	Masonic Cancer Center, University of Minnesota	P2	CCC (53)